Sami Mamand

Leicester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.

Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.

Journal: Molecular cancer
Published: May 06, 2025

FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells.

FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells.

Journal: Scientific reports
Published: April 15, 2025

Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling.

Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 21, 2024

IKKε and TBK1 in diffuse large B-cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF-κB and IL-10 signalling.

IKKε and TBK1 in diffuse large B-cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF-κB and IL-10 signalling.

Journal: Journal of cellular and molecular medicine
Published: April 23, 2020

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.

Journal: Blood advances
Published: October 07, 2019

Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.

Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.

Journal: PloS one
Published: December 28, 2018

Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

Journal: Blood advances
Published: October 29, 2018

PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma.

PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma.

Journal: Diagnostic pathology
Published: June 04, 2018

Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.

Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.

Journal: Scientific reports
Published: March 06, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026